Biogen Inc. (BIIB)

Trade BIIB now with
3/12/2018 7:33:42 AM Biogen Announces New Interim Phase 2 Results From NURTURE Evaluating The Efficacy And Safety Of SPINRAZA
3/12/2018 7:31:21 AM Biogen To Acquire From Pfizer First-in-Class Phase 2b Ready Asset For Cognitive Impairment Associated With Schizophrenia
3/2/2018 5:10:41 AM Biogen And AbbVie Announce Voluntary Worldwide Withdrawal Of Marketing Authorizations For ZINBRYTA
2/7/2018 7:31:09 AM Biogen Reports Top-Line Results From Phase 2b Study Of Natalizumab; Primary And Secondary Efficacy Endpoints Not Met
1/25/2018 6:30:43 AM Biogen FY Total Revenues $12.3 Bln, A 7% Increase Versus Prior Year
12/21/2017 7:01:16 AM Adaptive Phase II Study Of BAN2401 In Early Alzheimer’s Disease Continues Toward 18-Month Endpoint
12/4/2017 7:31:31 AM Biogen Appoints Mark Hernon As SVP, Chief Information Officer, Effective December 4